The Michael J. Fox Foundation supports research projects through six Requests for Applications (RFAs) that span our strategy to define, measure and treat Parkinson’s. Deadline for pre-proposals is October 22, 2020.
MJFF funding opportunities https://www.michaeljfox.org/webinar/mjff-funding-opportunities-spring-2021?em_cid=mc-a1b1R000008uUi6&et_cid=1676670&et_rid=225334131&et_lid=Register+Now.&em_id=%%
- Development and Validation of Improved Outcome Measures: Funds the development of biomarkers that can improve definitive diagnosis, objectively track the progression of disease, enrich for subject populations, or more precisely detect treatment response or target engagement.
- Target Advancement Program: Funds research to validate targets and define pathways implicated in Parkinson’s pathological processes and/or symptomology.
- Therapeutic Pipeline Program: Funds novel or repositioned, pre-clinical and clinical therapeutic intervention development for Parkinson’s. Specific interest in (1) developing therapeutics for non-motor symptoms and (2) telehealth-based therapeutic interventions.
Attend our webinar on September 3, 2020, at 12 p.m. ET to learn more about our Foundation's funding strategy and opportunities, and the application and review processes. Register Now.
The Outcomes Measures, Target Advancement and Therapeutic Pipeline programs are Edmond J. Safra Core Programs for PD Research.